Yuki Sato

2.0k total citations
40 papers, 276 citations indexed

About

Yuki Sato is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Yuki Sato has authored 40 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Yuki Sato's work include SARS-CoV-2 detection and testing (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Biosensors and Analytical Detection (3 papers). Yuki Sato is often cited by papers focused on SARS-CoV-2 detection and testing (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Biosensors and Analytical Detection (3 papers). Yuki Sato collaborates with scholars based in Japan, Australia and United States. Yuki Sato's co-authors include Minoru Nagata, Satoshi Takahashi, Yuka Sakai, Ryutaro Seo, Yasuki Kansha, Keisuke Tomii, Daichi Fujimoto, Yoshiki Suginoshita, Yoko Shibata and Yukihiro Imai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Yuki Sato

36 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Sato Japan 10 71 55 54 42 37 40 276
Jung Ran Kim South Korea 11 61 0.9× 48 0.9× 45 0.8× 12 0.3× 23 0.6× 25 423
Jingjing Ren China 11 45 0.6× 79 1.4× 43 0.8× 13 0.3× 35 0.9× 28 389
Eleni Gounari Greece 11 82 1.2× 99 1.8× 12 0.2× 16 0.4× 33 0.9× 26 360
Zachary Stillman United States 7 67 0.9× 122 2.2× 23 0.4× 17 0.4× 119 3.2× 8 352
Lingjun Zeng China 12 70 1.0× 187 3.4× 43 0.8× 13 0.3× 60 1.6× 37 385
Federica Leone Italy 11 107 1.5× 169 3.1× 15 0.3× 24 0.6× 92 2.5× 21 445
Md Mohosin Rana Canada 10 97 1.4× 101 1.8× 16 0.3× 19 0.5× 14 0.4× 19 306
Yiru Xia China 9 110 1.5× 87 1.6× 32 0.6× 11 0.3× 20 0.5× 14 359
Aiman Abu Ammar Israel 11 86 1.2× 44 0.8× 13 0.2× 10 0.2× 26 0.7× 25 415
Hongxiang Chen China 9 68 1.0× 44 0.8× 17 0.3× 8 0.2× 50 1.4× 15 271

Countries citing papers authored by Yuki Sato

Since Specialization
Citations

This map shows the geographic impact of Yuki Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Sato more than expected).

Fields of papers citing papers by Yuki Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Sato. The network helps show where Yuki Sato may publish in the future.

Co-authorship network of co-authors of Yuki Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Sato. A scholar is included among the top collaborators of Yuki Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Sato. Yuki Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Udagawa, Hibiki, Shingo Matsumoto, Hiroki Izumi, et al.. (2024). Efficacy of immunotherapy in first-line treatment for non-small cell lung cancer with HER2 mutation: Results from LC-SCRUM-Asia.. Journal of Clinical Oncology. 42(16_suppl). 8629–8629. 1 indexed citations
5.
Sato, Yuki, et al.. (2023). A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D. International Journal of Hematology. 118(4). 472–476.
6.
Sato, Yuki, et al.. (2023). Factors affecting the sensitivity of quantitative severe acute respiratory syndrome coronavirus 2 antigen test. Journal of Infection and Chemotherapy. 29(8). 754–758. 1 indexed citations
7.
Sato, Yuki, et al.. (2022). Does the timing of saliva collection affect the diagnosis of SARS-CoV-2 infection?. Journal of Infection and Chemotherapy. 28(7). 1012–1014. 2 indexed citations
8.
Sato, Yuki, et al.. (2022). Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detection. Journal of Infection and Chemotherapy. 28(7). 1033–1036. 5 indexed citations
9.
Fujiya, Yoshihiro, et al.. (2022). Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection. Journal of Infection and Chemotherapy. 28(11). 1590–1593. 6 indexed citations
10.
Sato, Yuki, et al.. (2022). Study of post-opening stability of active ingredients in hand sanitizers. Journal of Infection and Chemotherapy. 28(12). 1605–1609. 2 indexed citations
11.
Kondo, Takashi, et al.. (2022). Analysis of diagnostic performance and factors causing nonspecific reactions in SARS-CoV-2 rapid antigen detection tests. Journal of Infection and Chemotherapy. 29(2). 157–162. 1 indexed citations
12.
Sato, Yuki, et al.. (2022). A Prediction Model for Temperature Variation and Distribution Using Soft Sensing Method. SHILAP Revista de lepidopterología. 3 indexed citations
13.
Sato, Yuki, Yoshinori Tanino, Takefumi Nikaido, et al.. (2022). Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer. BMC Pulmonary Medicine. 22(1). 191–191. 2 indexed citations
14.
Suzuki, Rei, Tadayuki Takagi, Mitsuru Sugimoto, et al.. (2022). Intracellular C3 Modulates EMTviathe Akt/Smad Pathway in Pancreatic Cancer Cells. Anticancer Research. 42(12). 5743–5750. 4 indexed citations
15.
Sato, Yuki, et al.. (2021). Evaluation of two commercial molecular diagnostic assays: The Xpert Norovirus and the TRCReady NV. Journal of Infection and Chemotherapy. 27(7). 1115–1118. 2 indexed citations
16.
Sato, Yuki, Takashi Kondo, Ryo Kobayashi, et al.. (2021). Clinical performance and potential of a SARS-CoV-2 detection kit without RNA purification steps. SHILAP Revista de lepidopterología. 45(4-5). 205–212. 3 indexed citations
17.
Kobayashi, Ryo, Hitoshi Yonezawa, Takashi Kondoh, et al.. (2021). Evaluation of false positives in the SARS-CoV-2 quantitative antigen test. Journal of Infection and Chemotherapy. 27(10). 1477–1481. 10 indexed citations
18.
Takahashi, Ryo, et al.. (2014). Effect of Electrolysis Condition on the Lightness and Surface Morphology of Ni Deposited from Chloride Electro-Winning Solutions. Journal of the Japan Institute of Metals and Materials. 78(12). 427–433. 3 indexed citations
19.
Sato, Yuki, Daichi Fujimoto, Yoko Shibata, et al.. (2014). Fulminant Hepatitis Following Crizotinib Administration for ALK-positive Non-small-cell Lung Carcinoma. Japanese Journal of Clinical Oncology. 44(9). 872–875. 27 indexed citations
20.
Ueki, Yo, et al.. (2007). Norovirus GII/4 Variants Observed in Outbreaks of Gastroenteritis in Miyagi Prefecture between November and December of 2006. Japanese Journal of Infectious Diseases. 60(4). 240–241. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026